GT Biopharma, Inc. (GTBP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 8.92M | 8.11M | 3.56M | 7.12M | 2.66M | 4.23M | 6.76M | 9.27M | 9.88M | 14.06M | 16.05M | 18.02M |
| Cash & Short-Term Investments | 8.92M | 6.81M | 2.62M | 5.23M | 2.37M | 3.95M | 6.42M | 9.25M | 9.81M | 13.97M | 16.01M | 17.97M |
| Cash Only | 8.92M | 6.81M | 2.62M | 5.23M | 2.37M | 3.95M | 6.42M | 9.25M | 1.95M | 1.08M | 2.65M | 2.77M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.86M | 12.89M | 13.37M | 15.21M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 1.29M | 940K | 853K | 93K | 281K | 341K | 18K | 78K | 0 | 0 | 48K |
| Total Non-Current Assets | 0 | 0 | 760K | 0 | 0 | 0 | 0 | 0 | 27K | 53K | 96K | 123K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27K | 53K | 87K | 114K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 760K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9K | 9K |
| Total Assets | 10M | 8.11M | 4.32M | 7.12M | 2.66M | 4.23M | 6.76M | 9.27M | 9.91M | 14.11M | 16.15M | 18.14M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 276.07% | 91.54% | -36.07% | -23.13% | -73.18% | -70% | -58.14% | -48.93% | -50.65% | -15.7% | -23.36% | -24.93% |
| Total Current Liabilities | 2.42M | 2.32M | 1.32M | 2.31M | 3.64M | 5.9M | 4.66M | 3.76M | 4.6M | 6.63M | 5.09M | 4.84M |
| Accounts Payable | 253K | 748K | 769K | 1.37M | 2.38M | 3.85M | 2.61M | 1.72M | 3.21M | 4.33M | 3.97M | 3.5M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.16M | 1.57M | 552K | 325K | 126K | 252K | 182K | 277K | 394K | 1.05M | 0 | 0 |
| Current Ratio | 3.69x | 3.50x | 2.70x | 3.09x | 0.73x | 0.72x | 1.45x | 2.47x | 2.15x | 2.12x | 3.15x | 3.72x |
| Quick Ratio | 3.69x | 3.50x | 2.70x | 3.09x | 0.73x | 0.72x | 1.45x | 2.47x | 2.15x | 2.12x | 3.15x | 3.72x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.05M | 1.54M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.05M | 1.54M |
| Total Liabilities | 2.42M | 2.32M | 1.32M | 2.31M | 3.64M | 5.9M | 4.66M | 3.76M | 4.6M | 6.63M | 6.14M | 6.38M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30K | 58K | 92K | 120K |
| Net Debt | -8.92M | -6.81M | -2.62M | -5.23M | -2.37M | -3.95M | -6.42M | -9.25M | -1.92M | -1.02M | -2.56M | -2.65M |
| Debt / Equity | - | - | - | - | - | - | - | - | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -45.21x | -44.06x | - | - | - | - | - | - | - | - | - | -1991.00x |
| Total Equity | 7.58M | 5.79M | 3M | 4.82M | -980K | -1.67M | 2.1M | 5.51M | 5.31M | 7.48M | 10.01M | 11.76M |
| Equity Growth % | 873.47% | 446.53% | 43.06% | -12.55% | -118.45% | -122.34% | -79.04% | -53.18% | -59.3% | -36.29% | -37.29% | -23.81% |
| Book Value per Share | 0.25 | 1.05 | 0.76 | 1.74 | -0.42 | -0.88 | 0.94 | 3.22 | 3.85 | 5.41 | 7.32 | 8.78 |
| Total Shareholders' Equity | 7.58M | 5.79M | 3M | 4.82M | -980K | -1.67M | 2.1M | 5.51M | 5.31M | 7.48M | 10.01M | 11.76M |
| Common Stock | 35K | 26K | 6K | 3K | 3K | 2K | 2K | 2K | 1K | 1K | 42K | 41K |
| Retained Earnings | -726.84M | -723.9M | -700.78M | -697.52M | -696M | -695.23M | -691.45M | -688.04M | -684.33M | -682.07M | -679.1M | -676.69M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |